N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models

References

• Amat N, Umar A, Hoxur P, Anaydulla M, Imam G, Aziz R, Upur H, Kijjoa A, Moore N. 2015. Traditional uighur medicine karapxa decoction, inhibits liver xanthine oxidase and reduces serum uric acid concentrations in hyperuricemic mice and scavenges free radicals in vitro. BMC Complement Altern Med. 15(1):1–8.
   PubMed Web of Science ®Google Scholar
• Babasola O, Rees-Milton KJ, Bebe S, Wang JX, Anastassiades TP. 2014. Chemically modified N-acylated hyaluronan fragments modulate proinflammatory cytokine production by stimulated human macrophages. J Biol Chem. 289(36):24779–24791.
   PubMed Web of Science ®Google Scholar
• Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P. 2016. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 17(6):636–645.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. 2009. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 61(12):1704–1711.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Vaysbrot EE, Sullivan MC, McAlindon TE. 2014. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 43(5):593–599.
   PubMed Web of Science ®Google Scholar
• Bohm M, Vuppalanchi R, Chalasani N. 2016. Febuxostat-induced acute liver injury. Hepatology. 63(3):1047–1049.
   PubMed Web of Science ®Google Scholar
• Brandt KD. 1974. The effect of synovial hyaluronate on the ingestion of monosodium urate crystals by leukocytes. Clin Chim Acta. 55(3):307–315.
   PubMed Web of Science ®Google Scholar
• Busso N, So A. 2010. Mechanisms of inflammation in gout. Arthritis Res Ther. 12(2):206–208.
   PubMed Web of Science ®Google Scholar
• Campion EW, Glynn RJ, DeLabry LO. 1987. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med. 82(3):421–426.
   PubMedGoogle Scholar
• Campo GM, Avenoso A, Nastasi G, Micali A, Prestipino V, Vaccaro M, D'Ascola A, Calatroni A, Campo S. 2011. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta Mol Basis Dis. 1812(9):1170–1181.
   Web of Science ®Google Scholar
• Carrillo-Sepulveda MA, Spitler K, Pandey D, Berkowitz DE, Matsumoto T. 2015. Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats. J Mol Med. 93(12):1341–1354.
   PubMed Web of Science ®Google Scholar
• Chung WH, Wang CW, Dao RL. 2016. Severe cutaneous adverse drug reactions. J Dermatol. 43(7):758–766.
   PubMed Web of Science ®Google Scholar
• Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. 1985. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 44(12):817–822.
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Merriman TR, Stamp LK. 2016. Gout. Lancet. 388(10055):2039–2052.
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Milligan A, Doyle AJ, Clark B, McQueen FM. 2012. Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography. Arthritis Res Ther. 14(4):R165–R168.
   PubMed Web of Science ®Google Scholar
• Davey MW, Stals E, Panis B, Keulemans J, Swennen RL. 2005. High-throughput determination of malondialdehyde in plant tissues. Anal Biochem. 347(2):201–207.
   PubMed Web of Science ®Google Scholar
• Desai J, Steiger S, Anders HJ. 2017. Molecular pathophysiology of gout. Trends Mol Med. 23(8):756–768.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Michaud K. 2009. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 11(3):229–216.
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Hernandez-Diaz S. 2001. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res. 3(2):98–101.
   PubMedGoogle Scholar
• Greenhill CJ, Jones GW, Nowell MA, Newton Z, Harvey AK, Moideen AN, Collins FL, Bloom AC, Coll RC, Robertson AA, et al. 2014. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Res Ther. 16(4):1–10.
   Web of Science ®Google Scholar
• Guttmann A, Krasnokutsky S, Pillinger MH, Berhanu A. 2017. Pegloticase in gout treatment – safety issues, latest evidence and clinical considerations. Ther Adv Drug Saf. 8(12):379–388.
   PubMed Web of Science ®Google Scholar
• Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS. 2009. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 11(2):R46–R47.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Lin TY, Lu MK, Leng PJ, Tsao SM, Wu YC. 2017. Fucoidan induces toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer. Sci Rep. 7:1–13.
   PubMed Web of Science ®Google Scholar
• Huang JQ, Zhu MZ, Tao Y, Wang SW, Chen JZ, Sun WJ, Li SY. 2012. Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat. J Pharm Pharmacol. 64(8):1119–1127.
   PubMed Web of Science ®Google Scholar
• Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. 2017. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 356(6337):513–519.
   PubMed Web of Science ®Google Scholar
• Jiang KF, Guo S, Zhang T, Yang YP, Zhao G, Shaukat A, Wu HC, Deng GZ. 2018. Downregulation of TLR4 by MIR-181a provides negative feedback regulation to lipopolysaccharide-induced inflammation. Front Pharmacol. 9:1–13.
   PubMed Web of Science ®Google Scholar
• Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl JR, Hingoranis A, Jaques R, Nuki G, British Society R. 2007. British society for rheumatology and british health professionals in rheumatology guideline for the management of gout. Rheumatology (Oxford). 46(8):1372–1374.
   PubMed Web of Science ®Google Scholar
• Kanemitsu T, Tsurudome Y, Kusunose N, Oda M, Matsunaga N, Koyanagi S, Ohdo S. 2017. Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPARα. J Biol Chem. 292(52):21397–21406.
   PubMed Web of Science ®Google Scholar
• Keenan RT, Schlesinger N. 2016. New and pipeline drugs for gout. Curr Rheumatol Rep. 18(6):32.
   PubMed Web of Science ®Google Scholar
• Kienhorst LBE, van Lochem E, Kievit W, Dalbeth N, Merriman ME, Phipps-Green A, Loof A, van Heerde W, Vermeulen S, Stamp LK, et al. 2015. Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease. Arthritis Rheumatol. 67(12):3303–3313.
   PubMed Web of Science ®Google Scholar
• Knights KM, Mangoni AA, Miners JO. 2010. Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity. Expert Rev Clin Pharmacol. 3(6):769–776.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy A, Lazaro D, Stefanov DG, Blumenthal D, Gerber D, Patel S. 2017. The effect of allopurinol on renal function. J Clin Rheumatol. 23(1):1–5.
   PubMed Web of Science ®Google Scholar
• Kuo CF, Grainge MJ, Zhang WY, Doherty M. 2015. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 11(11):649–662.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Stevens LA, Zhang YP, Hendriksen S, Kusek JW, Van Lente F. 2006. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 145(4):247–254.
   PubMed Web of Science ®Google Scholar
• Liu XY, Chen RH, Shang YJ, Jiao BH, Huang CG. 2008. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats. Chem Biol Interact. 176(2/3):137–142.
   PubMed Web of Science ®Google Scholar
• Liu H, Xiong J, He T, Xiao T, Li Y, Yu Y, Huang Y, Xu X, Huang Y, Zhang J, et al. 2017. High uric acid-induced epithelial-mesenchymal transition of renal tubular epithelial cells via the TLR4/NF-κB signaling pathway. Am J Nephrol. 46(4):333–342.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Terkeltaub R. 2010. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous toll-like receptor 2/toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum. 62(7):2004–2012.
   PubMed Web of Science ®Google Scholar
• Ma LQ, Hu JB, Li JY, Yang Y, Zhang LK, Zou LY, Gao RF, Peng C, Wang Y, Luo T, et al. 2018. Bisphenol a promotes hyperuricemia via activating xanthine oxidase. Faseb J. 32(2):1007–1016.
   PubMed Web of Science ®Google Scholar
• Marcotti A, Miralles A, Dominguez E, Pascual E, Gomis A, Belmonte C, de la Pena E. 2018. Joint nociceptor nerve activity and pain in an animal model of acute gout and its modulation by intra-articular hyaluronan. Pain. 159(4):739–748.
   PubMed Web of Science ®Google Scholar
• Mason RM. 1954. Studies on the effect of probenecid (benemid) in gout. Ann Rheum Dis. 13(2):120–130.
   PubMed Web of Science ®Google Scholar
• Meneshian A, Bulkley GB. 2002. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation. 9(3):161–175.
   PubMed Web of Science ®Google Scholar
• Misra S, Hascall VC, Markwald RR, Ghatak S. 2015. Interactions between hyaluronan and its receptors (CD44, rhamm) regulate the activities of inflammation and cancer. Front Immunol. 6:1–31.
   PubMed Web of Science ®Google Scholar
• Nuki G, Simkin PA. 2006. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 8 (Suppl 1):S1.
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Dalbeth N, Urresola A, de Miguel E, Schlesinger N. 2009. Gout imaging of gout: findings and utility. Arthritis Res Ther. 11(3):232–238.
   PubMed Web of Science ®Google Scholar
• Petrilli V, Martinon F. 2007. The inflammasome, autoinflammatory diseases, and gout. Joint Bone Spine. 74(6):571–576.
   PubMed Web of Science ®Google Scholar
• Pushpakumar S, Ren L, Kundu S, Gamon A, Tyagi SC, Sen U. 2017. Toll-like receptor 4 deficiency reduces oxidative stress and macrophage mediated inflammation in hypertensive kidney. Sci Rep. 7(1):15.
   Web of Science ®Google Scholar
• Ragab G, Elshahaly M, Bardin T. 2017. Gout: an old disease in new perspective – a review. J Adv Res. 8(5):495–511.
   PubMed Web of Science ®Google Scholar
• Rizzuto VJ, Inglesby TV, Grace WJ. 1965. Probenecid (benemid) intoxication with status epilepticus. Am J Med. 38:646–648.
   PubMed Web of Science ®Google Scholar
• Roddy E, Doherty M. 2012. Gout and osteoarthritis: a pathogenetic link? Joint Bone Spine. 79(5):425–427.
   PubMed Web of Science ®Google Scholar
• Sabina EP, Nagar S, Rasool M. 2011. A role of piperine on monosodium urate crystal-induced inflammation – an experimental model of gouty arthritis. Inflammation. 34(3):184–192.
   PubMed Web of Science ®Google Scholar
• Sahnoun S, Sellami A, Chakroun N, Mseddi M, Attia H, Rebai T, Lassoued S. 2017. Human sperm toll-like receptor 4 (TLR4) mediates acrosome reaction, oxidative stress markers, and sperm parameters in response to bacterial lipopolysaccharide in infertile men. J Assist Reprod Genet. 34(8):1067–1077.
   PubMed Web of Science ®Google Scholar
• Sanchez-Nino MD, Zheng-Lin B, Valino-Rivas L, Sanz AB, Ramos AM, Luno J, Goicoechea M, Ortiz A. 2017. Lesinurad: what the nephrologist should know. Clin Kidney J. 10(5):679–687.
   PubMed Web of Science ®Google Scholar
• Singh NP, Ganguli A, Prakash A. 2003. Drug-induced kidney diseases. J Assoc Phys India. 51:970–979.
   PubMedGoogle Scholar
• Singh D, Kumar V, Singh C. 2017. IFN-gamma regulates xanthine oxidase-mediated iNOS-independent oxidative stress in maneb- and paraquat-treated rat polymorphonuclear leukocytes. Mol Cell Biochem. 427(1/2):133–143.
   PubMed Web of Science ®Google Scholar
• So A, De Smedt T, Revaz S, Tschopp J. 2007. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 9(2):1–6.
   Web of Science ®Google Scholar
• Stridh S, Palm F, Hansell P. 2012. Renal interstitial hyaluronan: functional aspects during normal and pathological conditions. Am J Physiol Regul Integr Comp Physiol. 302(11):R1235–R1249.
   PubMed Web of Science ®Google Scholar
• Tan AS, Berridge MV. 2000. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods. 238(1/2):59–68.
   PubMed Web of Science ®Google Scholar
• Terkeltaub R. 2009. Novel therapies for treatment of gout and hyperuricemia. Arthritis Res Ther. 11(4):236–211.
   PubMed Web of Science ®Google Scholar
• Terkeltaub R. 2017. What makes gouty inflammation so variable? BMC Med. 15(1):1–10.
   PubMed Web of Science ®Google Scholar
• Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. 2006. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 290(2):F517–F529.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39(1):44–84.
   PubMed Web of Science ®Google Scholar
• Van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D. 2014. Colchicine for acute gout. Cochrane Database Syst Rev. (8):CD006190.
   PubMed Web of Science ®Google Scholar
• Vlahopoulos S, Boldogh I, Casola A, Brasier AR. 1999. Nuclear factor-kappa B-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood. 94(6):1878–1889.
   PubMed Web of Science ®Google Scholar
• Wann AK, Mistry J, Blain EJ, Michael-Titus AT, Knight MM. 2010. Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Res Ther. 12(6):R207.
   PubMed Web of Science ®Google Scholar
• Wu XW, Lee CC, Muzny DM, Caskey CT. 1989. Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci USA. 86(23):9412–9416.
   PubMed Web of Science ®Google Scholar
• Xia MD, Sui ZH. 2009. Recent developments in CCR2 antagonists. Expert Opin Ther Pat. 19(3):295–303.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Lin FF, Liu SM, Sui XF. 2017. Influence of the total saponin fraction from Dioscorea nipponica Makino on TLR2/4-IL1r receptor singnal pathway in rats of gouty arthritis. J Ethnopharmacol. 206:274–282.
   PubMed Web of Science ®Google Scholar